Innospec Statistics
Total Valuation
Innospec has a market cap or net worth of $2.86 billion. The enterprise value is $2.60 billion.
Important Dates
The next confirmed earnings date is Tuesday, February 18, 2025, after market close.
| Earnings Date | Feb 18, 2025 |
| Ex-Dividend Date | Nov 18, 2024 |
Share Statistics
Innospec has 24.94 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 24.94M |
| Shares Outstanding | 24.94M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 99.17% |
| Float | 24.65M |
Valuation Ratios
The trailing PE ratio is 19.98 and the forward PE ratio is 19.61. Innospec's PEG ratio is 2.61.
| PE Ratio | 19.98 |
| Forward PE | 19.61 |
| PS Ratio | 1.52 |
| Forward PS | 1.51 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 3.63 |
| P/FCF Ratio | 15.43 |
| P/OCF Ratio | 12.35 |
| PEG Ratio | 2.61 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.81, with an EV/FCF ratio of 14.04.
| EV / Earnings | 18.06 |
| EV / Sales | 1.39 |
| EV / EBITDA | 10.81 |
| EV / EBIT | 13.12 |
| EV / FCF | 14.04 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.59 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.25 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.11% and return on invested capital (ROIC) is 10.04%.
| Return on Equity (ROE) | 12.11% |
| Return on Assets (ROA) | 7.24% |
| Return on Capital (ROIC) | 10.04% |
| Revenue Per Employee | $780,542 |
| Profits Per Employee | $59,917 |
| Employee Count | 2,400 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 4.01 |
Taxes
In the past 12 months, Innospec has paid $45.30 million in taxes.
| Income Tax | 45.30M |
| Effective Tax Rate | 23.96% |
Stock Price Statistics
The stock price has decreased by -1.31% in the last 52 weeks. The beta is 1.08, so Innospec's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -1.31% |
| 50-Day Moving Average | 114.94 |
| 200-Day Moving Average | 118.06 |
| Relative Strength Index (RSI) | 58.69 |
| Average Volume (20 Days) | 145,440 |
Short Selling Information
The latest short interest is 383,995, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 383,995 |
| Short Previous Month | 299,831 |
| Short % of Shares Out | 1.54% |
| Short % of Float | 1.56% |
| Short Ratio (days to cover) | 2.73 |
Income Statement
In the last 12 months, Innospec had revenue of $1.87 billion and earned $143.80 million in profits. Earnings per share was $5.73.
| Revenue | 1.87B |
| Gross Profit | 567.40M |
| Operating Income | 197.90M |
| Pretax Income | 191.80M |
| Net Income | 143.80M |
| EBITDA | 240.30M |
| EBIT | 197.90M |
| Earnings Per Share (EPS) | $5.73 |
Full Income StatementBalance Sheet
The company has $303.80 million in cash and $45.70 million in debt, giving a net cash position of $258.10 million or $10.35 per share.
| Cash & Cash Equivalents | 303.80M |
| Total Debt | 45.70M |
| Net Cash | 258.10M |
| Net Cash Per Share | $10.35 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 49.85 |
| Working Capital | 592.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $231.20 million and capital expenditures -$46.20 million, giving a free cash flow of $185.00 million.
| Operating Cash Flow | 231.20M |
| Capital Expenditures | -46.20M |
| Free Cash Flow | 185.00M |
| FCF Per Share | $7.42 |
Full Cash Flow StatementMargins
Gross margin is 30.29%, with operating and profit margins of 10.56% and 7.68%.
| Gross Margin | 30.29% |
| Operating Margin | 10.56% |
| Pretax Margin | 10.09% |
| Profit Margin | 7.68% |
| EBITDA Margin | 12.83% |
| EBIT Margin | 10.56% |
| FCF Margin | 9.88% |